Literature DB >> 28971570

Chondroblastoma of extra-craniofacial bones: Clinicopathological analyses of 103 cases.

Eiichi Konishi1, Yasuaki Nakashima2, Masayuki Mano3, Yasuhiko Tomita4, Toshikazu Kubo5, Nobuhito Araki6, Eiichi Morii7, Hideki Yoshikawa8, Hironori Haga2, Junya Toguchida9, Takafumi Ueda10, Masahiko Osawa11, Manabu Hoshi12, Takeshi Inoue13, Masanari Aono14, Akio Yanagisawa1.   

Abstract

We elucidated clinicopathological characteristics of chondroblastoma (CB) in Japan, and reliable clinicopathologic parameters predicting local recurrence and/or metastasis. Clinicopathological profiles of 103 CB (80 male, 23 female) in extra-craniofacial bones were retrieved. Numerical scoring of nine pathological and five radiological features was statistically analyzed to determine prognostic significance. Age ranged 8-61 years (average 19.6 years). Frequently involved sites were femur, tibia, calcaneus, patella and humerus. Radiologically, tumors were 2-80 mm (average 31.1 mm) in size. Marginal sclerosis and calcification were common. Histologically, pink cartilage, mitoses, and chicken-wire calcification were often seen. Within a follow-up period [2-260 months (average 53.5 months)], the local recurrence rate was 15.5%. No patient had metastasis. Recurrence was most frequently observed at the femur. By log-rank analysis, only cyst formation in images was significant for predicting recurrence free survival (RFS). By Cox hazard analysis with representative clinico-radiological and pathological features, only age (≥16 years) and cyst formation were significant predictors for RFS. Pathological features were not significant in both uni- and multivariate analyses.
© 2017 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bone; chondroblastoma; extra-craniofacial; pathology; predictor; radiology; recurrence; statistics

Mesh:

Year:  2017        PMID: 28971570     DOI: 10.1111/pin.12586

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Clinical features, treatments and long-term follow-up outcomes of spinal chondroblastoma: report of 13 clinical cases in a single center.

Authors:  Qi Jia; Chao Liu; Jian Yang; Yong Ji; Haifeng Wei; Tielong Liu; Xinghai Yang; Cheng Yang; Jianru Xiao
Journal:  J Neurooncol       Date:  2018-07-02       Impact factor: 4.130

Review 2.  Chondroblastoma of the patella with secondary aneurysmal bone cyst, an easily misdiagnosed bone tumor:a case report with literature review.

Authors:  Jianping Zheng; Ningkui Niu; Jiandang Shi; Xu Zhang; Xi Zhu; Jiali Wang; Changhao Liu
Journal:  BMC Musculoskelet Disord       Date:  2021-04-23       Impact factor: 2.362

3.  Chondroblastoma in pelvis and extremities- a signle centre study of 177 cases.

Authors:  M K Laitinen; J D Stevenson; S Evans; A Abudu; V Sumathi; L M Jeys; M C Parry
Journal:  J Bone Oncol       Date:  2019-06-27       Impact factor: 4.072

4.  Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis.

Authors:  Yajuan J Liu; Wenjing Wang; Jeffrey Yeh; Yu Wu; Jose G Mantilla; Christopher D M Fletcher; Robert W Ricciotti; Eleanor Y Chen
Journal:  Mod Pathol       Date:  2021-03-16       Impact factor: 7.842

5.  Letter to the Editor concerning the article "Clinical outcomes of chondroblastoma treated using synthetic bone substitute: risk factors for developing radiographic joint degeneration".

Authors:  Bo-Wen Zheng; Bo-Yv Zheng; Hua-Qing Niu; Xiao-Bin Wang; Jing Li
Journal:  World J Surg Oncol       Date:  2021-06-12       Impact factor: 2.754

6.  Sacral chondroblastoma - a rare location, a rare pathology: A case report and review of literature.

Authors:  Bo-Wen Zheng; Hua-Qing Niu; Xiao-Bin Wang; Jing Li
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

7.  Prognostic Significance of Tumor-Associated Macrophages in Chondroblastoma and Their Association with Response to Adjuvant Radiotherapy.

Authors:  Yi-Guo Yan; Ming-Xiang Zou; Bo-Wen Zheng; Min-Liang Yang; Wei Huang; Bo-Yv Zheng; Tao-Lan Zhang; Jing Li; Guo-Hua Lv
Journal:  J Inflamm Res       Date:  2021-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.